OMB APPROVAL
OMB Number:	3235-0145
Estimated average burden hours per response………. .10.4

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13d-2 (b)

(Amendment No. 1)*

Cardiome Pharma Corp.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

14159U202

(CUSIP Number)

December 31, 2010

(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-(c)

¨ Rule 13d-1(d)

* This amends a Schedule 13G filed on February 12, 2010, by Allianz Global Investors Management Partners LLC (“AGIMP”), a wholly-owned subsidiary of Allianz Global Investors of America L.P. (“AGI LP”), and AGIMP’s wholly-owned subsidiaries, NFJ Investment Group LLC (“NFJ”), Nicholas-Applegate Capital Management LLC (“NACM”) and Oppenheimer Capital LLC (“OpCap”). Those filers have been reorganized and as part of that reorganization, NACM and OpCap ceased operations and AGIMP changed its name to Allianz Global Investors Capital LLC (“AGIC”). NFJ remains a wholly-owned subsidiary of AGIC, which remains a wholly-owned subsidiary of AGI LP. Investment advisory accounts that were managed by NACM and OpCap are now managed by AGIC.

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

  CUSIP NO. 14159U202   13G   Page 2 of 5 Pages

1	NAME OF REPORTING PERSON ALLIANZ GLOBAL INVESTORS CAPITAL LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)  ¨        (b)  x
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION     Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5	SOLE VOTING POWER     1,464,552
		6	SHARED VOTING POWER     0
		7	SOLE DISPOSITIVE POWER     2,135,253
		8	SHARED DISPOSITIVE POWER     0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     2,135,253
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*			¨
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)     3.5%
12	TYPE OF REPORTING PERSON*     IA, OO

  CUSIP NO. 14159U202   13G   Page 3 of 5 Pages

Item 1	(a)	Name of Issuer:
		Cardiome Pharma Corp.
	(b)	Address of Issuer’s Principal Executive Offices:
		6190 Agronomy Road, 6th Floor
		Vancouver, British Columbia, V6T 1Z3, Canada
Item 2	(a)	Name of Person Filing:
		Allianz Global Investors Capital LLC (“AGIC”)
	(b)	Address of Principal Business Office:
		600 West Broadway, Suite 2900, San Diego, CA 92101
	(c)	Citizenship:
		Delaware
	(d)	Title of Class of Securities:
		Common Shares
	(e)	CUSIP Number:
		14159U202
Item 3	If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:
(a)	¨ Broker or dealer registered under Section 15 of the Act;
(b)	¨ Bank as defined in Section 3(a)(6) of the Act;
(c)	¨ Insurance company as defined in Section 3(a)(19) of the Act;
(d)	¨ Investment company registered under Section 8 of the Investment Company Act of 1940, as amended (the       “Investment Company Act”);
(e)	x Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f)	¨ Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
(g)	¨ Parent holding company or control person, in accordance with 13d-1(b)(ii)(G);
(h)	¨ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
(i)	¨ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment      Company Act;
(j)	¨ A non-U.S. institution in accordance with §240.13d-1(b)(ii)(J); or
(k)	¨ Group, in accordance with Rule13d-1(b)(1)(ii)(K);
	If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution                                                                                   .

  CUSIP NO. 14159U202   13G   Page 4 of 5 Pages

Item 4	Ownership.
(a)	Amount beneficially owned: 2,135,253
(b)	Percent of Class: 3.5%
(c)	Number of shares as to which such person has:
	(i)	Sole power to vote or direct the vote:
		1,464,552
	(ii)	Shared power to vote: 0
	(iii)	Sole power to dispose or direct the disposition of:
		2,135,253
	(iv)	Shared power to dispose or direct the disposition of: 0

AGIC is an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, as amended, and is a wholly-owned subsidiary of Allianz Global Investors of America L.P. (“AGI LP”).

The securities reported herein are held by investment advisory clients or discretionary accounts of which AGIC is the investment adviser. Investment advisory contracts grant to AGIC voting and/or investment power over the securities held by its clients or in accounts that it manages. As a result, AGIC may be deemed to beneficially own the securities held by its clients or accounts within the meaning of rule 13d-3 under the Act.

In conformity with the guidelines articulated by the SEC staff in Release No. 34-39538 (January 12, 1998) relating to organizations in which related entities exercise voting and investment powers over the securities being reported independently from each other, this filing does not reflect securities beneficially owned by affiliates of AGI LP other than AGIC. The voting and investment powers held by AGIC are exercised independently from AGI LP’s other affiliates, other than AGIC’s wholly-owned subsidiary, NFJ Investment Group LLC (“NFJ”), an investment adviser that does not advise accounts that hold, and does not otherwise beneficially own, any of the securities reported on this Schedule 13G. Internal policies and procedures of AGIC and NFJ establish informational barriers that prevent the flow between them and the rest of AGI LP’s affiliates of information that relates to the voting and investment powers over the securities held in the accounts that AGIC and NFJ manage. Consequently, AGIC and NFJ report the securities over which they hold investment and voting power separately from AGI LP and its other affiliates for purposes of Section 13 of the Act.

AGIC believes that none of AGIC, NFJ, AGI LP or any of AGI LP’s other affiliates constitute a “group” within the meaning of Rule 13d-5 under the Act and that they are not otherwise required to attribute to each other the beneficial ownership of the securities reported herein held by any of them or by any persons or entities for whom or for which AGIC, NFJ or such other affiliates provide investment management services. AGIC also disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.

  CUSIP NO. 14159U202   13G   Page 5 of 5 Pages

Item 5 Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  x.

Item 6 Ownership of More than Five Percent on Behalf of Another Person.

Each client of AGIC has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the securities reported herein. No one client holds more than five percent of such securities.

Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not Applicable.

Item 8 Identification and Classification of Members of the Group.

Not Applicable.

Item 9 Notice of Dissolution of Group.

Not Applicable.

Item 10 Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 10, 2011

ALLIANZ GLOBAL INVESTORS CAPITAL LLC
By:	/s/ Kellie E. Davidson
	Kellie E. Davidson, Secretary